Global Rank
#48435
Country Rank
n/a
Market Cap
427,519.47
Price
0.04
Change (%)
19.48%
Volume
299,949
SL Therapeutics's latest marketcap:
427,519.47
As of 05/07/2025, SL Therapeutics's market capitalization has reached $427,519.47. According to our data, SL Therapeutics is the 48435th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 427,519.47 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 5.21 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 05/07/2025
SL Therapeutics's yearly market capitalization.
SL Therapeutics has seen its market value drop from ₩27.46 B to ₩599.61 M since 2020, representing a total decrease of 97.82% and an annual compound decline rate (CAGR) of 58.47%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/07/2025 | ₩599.61 M | -86.42% |
| 12/30/2024 | ₩4.42 B | 43.8% |
| 12/28/2023 | ₩3.07 B | -83.07% |
| 12/29/2022 | ₩18.14 B | -35.44% |
| 12/30/2021 | ₩28.1 B | 2.34% |
| 12/30/2020 | ₩27.46 B |
Company Profile
About SL Therapeutics, Inc.
SL Therapeutics, Inc. is a biotechnology company specializing in cell therapy and medical device innovation. The company focuses on developing advanced therapeutic solutions to address a range of medical conditions.
Core Business Areas
- Cell Therapy: Utilizes proprietary cell reprogramming technology to target spinal cord injuries, age-related diseases, and genetic disorders. Key areas include hair follicle cells, skin cells, and central nervous system cells.
- Medical Devices: Manufactures automated MRI systems and bone mineral density measurement devices, including the Supra Elite and Dexino models.
Company Background
Originally founded as StemLab Inc. in 2011, the company rebranded to SL Therapeutics, Inc. and is headquartered in Seoul, South Korea.
Frequently Asked Questions
-
What is SL Therapeutics's (XKON-258540) current market cap?As of 05/07/2025, SL Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $427,519.47 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does SL Therapeutics (XKON-258540) rank globally by market cap?SL Therapeutics global market capitalization ranking is approximately 48435 as of 05/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.